News
Architecture firm Page is full of design masters. So what did they come up with for their own new skyscraping office downtown? Have a look in this Office Envy feature.
Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...
Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...
Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five ...
1d
Pharmaceutical Technology on MSNBMS and Bain Capital forge $300m immunology spinoff
The biopharma spinoff will advance the development of its five investigational therapies designed to treat autoimmune disease.
BI asked Gradient's co-founder and CEO how he was able to close so quickly and what his advice is for other founders who are ...
Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...
The $3 bln education publisher McGraw Hill and $6 bln research firm NIQ thudded onto the market this week. Both lose money ...
Feeling stalled in life in the face of economic obstacles, young Chinese consumers are finding comfort in “small indulgences” such as milk tea and Labubu figurines.
As London Climate Week proves, the work goes on, but the U.S. is no longer at the center of the climate universe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results